The effect of resveratrol on the werner syndrome recq helicase gene and telomerase activity

Current Aging Science

Volumn 4, Issue 1, 2011, Pages 1-7

  Uchiumi, Fumiaki ^a   Watanabe, Takeshi ^a   Hasegawa, Shin ^a   Hoshi, Taisuke ^a   Higami, Yoshikazu ^a   Tanuma, Sei ichi ^a  

^a TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

Blm; Resveratrol; Sp1; Telomerase; Tert; Wrn

Indexed keywords

RECQ HELICASE; RESVERATROL; TELOMERASE; UNCLASSIFIED DRUG; WERNER SYNDROME PROTEIN; WERNER SYNDROME RECQ HELICASE; ANTIOXIDANT; EXODEOXYRIBONUCLEASE; STILBENE DERIVATIVE; WRN PROTEIN, HUMAN;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION REGULATION; HELA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TRANSCRIPTION INITIATION; CELL SURVIVAL; DOSE RESPONSE; DRUG EFFECT; ENZYMOLOGY; GENETICS; METABOLISM; PATHOLOGY; UPREGULATION; UTERINE CERVIX TUMOR;

ANTIOXIDANTS; CELL PROLIFERATION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EXODEOXYRIBONUCLEASES; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HELA CELLS; HUMANS; PROMOTER REGIONS, GENETIC; RECQ HELICASES; STILBENES; TELOMERASE; UP-REGULATION; UTERINE CERVICAL NEOPLASMS;

EID: 79958782315     PISSN: 18746098     EISSN: 18746128     Source Type: Journal    
DOI: 10.2174/1874609811104010001     Document Type: Article

References (28)

1. Sanz A and Stefanatos RKA. The mitochondrial free radical theory of aging: A critical view. Curr Aging Sci 2008; 1: 10-21.
2. Campisi J and d'Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 2007; 8: 729-40.
3. Kuningas M, Mooijaart SP, van Heemst D, Zwaan BJ, Slagboom PE and Westerndorp RGJ. Genes encoding longevity: from model organisms to humans. Aging Cell 2008; 7: 270-80.
4. Blackburn EH. A history of telomere biology. In: de Lange T, Lundblad V, Blackburn E, Eds. Telomeres. 2nd ed. Plainview, NY: Cold Spring Harbor Laboratory Press 2006; pp. 1-19.
5. Harley CB, Futcher AB and Greider CW. Telomeres shorten during aging of human fibroblasts. Nature 1990; 345: 458-60.
6. Oberdoerffer P and Sinclair DA. The role of nuclear architecture in genomic instability and aging. Nat Rev Mol Cell Biol 2007; 8: 692-702.
7. Chu WK and Hickson ID. RecQ helicases: multifunctional genome caretakers. Nat Rev Cancer 2009; 9: 644-54.
8. Yu BP and Chung HY. Adaptive mechanisms to oxidative stress during aging. Mech Aging Dev 2006; 127: 436-43.
9. Bokov A, Chaudhuri A and Richardson A. The role of oxidative damage and stress in aging. Mech Aging Dev 2004; 125: 811-26.
10. Cavallini G, Donati A, Gori Z and Bergamini E. Towards an understanding of the anti-aging mechanism of caloric restriction. Curr Aging Sci 2008; 1: 4-9.
11. Sinclair DA. Toward a unified theory of caloric restriction and longevity regulation. Mech Ageing Dev 2005; 126: 987-1002.
12. Stefani M, Markus MA, Lin RCY, Pinese M, Dawes IW and Morris BJ. The effect of resveratrol on a cell model of human aging. Ann NY Acad Sci 2007; 1114: 407-18.
13. Knutson MD and Leeuwenburgh C. Resveratrol and novel potent activators of SIRT1: effects on aging and age-related diseases. Nutr Rev 2008; 66: 591-6.
14. Bass TM, Weinkove D, Houthoofd K, et al. Effects of resveratrol on lifespan in Drosophila melanogaster and Caenorhabditis elegans. Mech Aging Dev 2007; 128: 546-52.
15. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, et al. Resveratrol improves health and survival of mice on a highcalorie diet. Nature 2006; 444: 337-42.
16. Zhou B, Ikejima T, Watanabe T, Iwakoshi K, Idei Y, Tanuma S, et al. The effect of 2-deoxy-D-glucose on Werner syndrome RecQ helicase gene. FEBS Lett 2009; 583: 1331-6.
17. Uchiumi F, Watanabe T and Tanuma S. Characterization of various promoter regions of human DNA helicase-encoding genes and identification of duplicated ets (GGAA) motifs as an essential transcription regulatory element. Exp Cell Res 2010; 316: 1523-34.
18. Uchiumi F, Sakakibara G, Sato J and Tanuma S. Characterization of the promoter region of the human PARG gene and its response to PU.1 during differentiation of HL-60 cells. Genes Cells 2008; 13: 1229-48.
19. Schulz VP and Zakian VA. The saccharomyces PIF1 DNA helicase inhibits telomere elongation and de novo telomere formation. Cell 1994; 76: 145-155.
20. Lin K, Dorman JB, Rodan A and Kenyon C. DAF-16: an HNF- 3/forkhead family member that can function to double the life-span of Caenorhabditis elegans. Science 1997; 278: 1319-22.
21. Ogg S, Paradis S, Gottlieb S, Patterson GI, Lee L, Tissenbaum HA, et al. The Fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans. Nature 1997;389: 994-9.
22. Roth GS, Ingram DK and Lane MA. Caloric restriction in primates and relevance to humans. Ann NY Acad Sci 2001; 928: 305-15.
23. Xia L, Wang XX, Hu XS, Guo XG, Shang YP, Chen HJ, et al. Resveratrol reduces endothelial progenitor cells senescence through augmentation of telomerase activity by Akt-dependent mechanisms. Br J Pharmacol 2008; 155: 387-94.
24. Lanzilli G, Fuggetta MP, Tricarico, M, Cottarelli A, Serafino A, Falchetti R, et al. Resveratrol down-regulates the growth and telomerase activity of breast cancer cells in vitro. Int J Oncol 2006;28: 641-8.
25. Gatz SA, Keimling M, Baumann C, Dork T, Debatin K-M, Fulda S, et al. Resveratrol modulates DNA double-strand break repair pathways in an ATM/ATR -p53 and -Nbs1 -dependent manner. Carcinogenesis 2008; 29: 519-27.
26. Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α. Cell 2006; 127: 1109-22.
27. van der Horst A and Burgering BMT. Stressing the role of FoxO roteins in lifespan and disease. Nat Rev Mol Cell Biol 2007; 8: 440-50.
28. Manna SK, Mukhopadhyay A and Aggarwal BB. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-κ activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. J Immunol Meth 2000; 164: 6509-19.